Trial intelligence / Profile preview

Effect of Ketamine on Intraoperative MEPs

NCT06140927Phase 3Recruiting

Sponsor
University of California, San Francisco
Start
Dec 2023
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ketamine in pain, sponsored by University of California, San Francisco. Started Dec 2023; status: recruiting.

02

Drugs

ketamine
03

Conditions

pain

Beyond the preview

Go deeper on NCT06140927.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06140927.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call